Low Frequency of Lynch Syndrome Among Young Patients With Non-Familial Colorectal Cancer

被引:60
|
作者
Goel, Ajay
Nagasaka, Takeshi [2 ]
Spiegel, Jennifer [3 ]
Meyer, Richard [3 ]
Lichliter, Warren E. [4 ]
Boland, C. Richard [1 ]
机构
[1] Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab,Charles A Sammons C, Dept Internal Med,Div Gastroenterol, Dallas, TX 75246 USA
[2] Okayama Univ, Dept Gastroenterol Surg & Surg Oncol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan
[3] Baylor Univ, Dept Pathol, Med Ctr, Dallas, TX 75246 USA
[4] Baylor Univ, Div Colorectal Surg, Med Ctr, Dallas, TX 75246 USA
基金
美国国家卫生研究院;
关键词
Colon Cancer; Young Patients; Familial Colorectal Cancer; MICROSATELLITE INSTABILITY; GERMLINE MUTATIONS; GENES; PMS2; PREDISPOSITION; CRITERIA; DISEASE;
D O I
10.1016/j.cgh.2010.06.030
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS Colorectal cancer (CRC) is uncommon in individuals <50 years old Lynch syndrome is caused by germline mutations in DNA mismatch repair (MMR) genes and associated with early onset CRC, but little is known about the proportion of young patients with apparently sporadic CRC who actually have Lynch syndrome We examined patterns of microsatellite instability (MSI) and MMR genes among patients <50 years old with non familial CRC (patients with not more than 1 family member with CRC) METHODS Tissue specimens were collected from 75 CRC patients <50 years old (mean age, 34 5 years) and analyzed using immunohistochemical analyses of MLH1, MSH2, MSH6, and PMS2 MSI and mutations in BRAF and KRAS were also analyzed RESULTS Most cancers (72%) arose in the distal colon MSI was detected in 21% of the samples, and loss of 1 or more MMR proteins was observed in 21% Interestingly, only 38% of the MMR deficient CRCs lost either MLH1 or MSH2, whereas 63% of the MMR deficient CRC samples lost either PMS2 or MSH6 All 11 CRC samples that had lost MSH2, MLH1, or PMS2 had MSI, but only 2 of the 5 tumors that lost only MSH6 had MSI There were no BRAF mutations in any tumor CONCLUSIONS In young patients with apparently sporadic CRC, most tumors arise in the distal colon, only 21% have features of Lynch syndrome Loss of MSH6 or PMS2 occurred in 13 3% of these tumors Most tumors that lose MSH6 will not be detected in screens for MSI, CRC screening might be modified to identify more patients with Lynch syndrome
引用
收藏
页码:966 / 971
页数:6
相关论文
共 50 条
  • [1] Characterisation of Familial Colorectal Cancer Type X, Lynch syndrome, and non-familial colorectal cancer
    Shiovitz, S.
    Copeland, W. K.
    Passarelli, M. N.
    Burnett-Hartman, A. N.
    Grady, W. M.
    Potter, J. D.
    Gallinger, S.
    Buchanan, D. D.
    Rosty, C.
    Win, A. K.
    Jenkins, M.
    Thibodeau, S. N.
    Haile, R.
    Baron, J. A.
    Marchand, L. L.
    Newcomb, P. A.
    Lindor, N. M.
    BRITISH JOURNAL OF CANCER, 2014, 111 (03) : 598 - 602
  • [2] Characterisation of Familial Colorectal Cancer Type X, Lynch syndrome, and non-familial colorectal cancer
    S Shiovitz
    W K Copeland
    M N Passarelli
    A N Burnett-Hartman
    W M Grady
    J D Potter
    S Gallinger
    D D Buchanan
    C Rosty
    A K Win
    M Jenkins
    S N Thibodeau
    R Haile
    J A Baron
    L L Marchand
    P A Newcomb
    N M Lindor
    British Journal of Cancer, 2014, 111 : 598 - 602
  • [3] Genetic and epigenetic alterations in young, non-familial colorectal cancer patients
    Jung, Woon-Tae
    Nagasaka, Takeshi
    Goel, Ajay
    Boland, C. R.
    GASTROENTEROLOGY, 2008, 134 (04) : A615 - A615
  • [4] Familial and non-familial risk factors associated with colorectal cancer survival in young and middle-aged patients
    Kelty, Erin
    Ward, Sarah V.
    Cadby, Gemma
    McCarthy, Nina S.
    O'Leary, Peter
    Moses, Eric K.
    Ee, Hooi C.
    Preen, David B.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2019, 34 (10) : 1673 - 1680
  • [5] Familial and non-familial risk factors associated with colorectal cancer survival in young and middle-aged patients
    Erin Kelty
    Sarah V. Ward
    Gemma Cadby
    Nina S. McCarthy
    Peter O’Leary
    Eric K. Moses
    Hooi C. Ee
    David B. Preen
    International Journal of Colorectal Disease, 2019, 34 : 1673 - 1680
  • [6] Identification of Lynch Syndrome Among Patients With Colorectal Cancer
    Moreira, Leticia
    Balaguer, Francesc
    Lindor, Noralane
    de la Chapelle, Albert
    Hampel, Heather
    Aaltonen, Lauri A.
    Hopper, John L.
    Le Marchand, Loic
    Gallinger, Steven
    Newcomb, Polly A.
    Haile, Robert
    Thibodeau, Stephen N.
    Gunawardena, Shanaka
    Jenkins, Mark A.
    Buchanan, Daniel D.
    Potter, John D.
    Baron, John A.
    Ahnen, Dennis J.
    Moreno, Victor
    Andreu, Montserrat
    de Leon, Maurizio Ponz
    Rustgi, Anil K.
    Castells, Antoni
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (15): : 1555 - 1565
  • [8] Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer
    Hampel, Heather
    Frankel, Wendy L.
    Martin, Edward
    Arnold, Mark
    Khanduja, Karamjit
    Kuebler, Philip
    Clendenning, Mark
    Sotamaa, Kaisa
    Prior, Thomas
    Westman, Judith A.
    Panescu, Jenny
    Fix, Dan
    Lockman, Janet
    LaJeunesse, Jennifer
    Comeras, Ilene
    de la Chapelle, Albert
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) : 5783 - 5788
  • [9] Interpretation of Genetic Testing for Lynch Syndrome in Patients With Putative Familial Colorectal Cancer
    Rybak, Christina
    Hall, Michael J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (11): : 1311 - 1320
  • [10] Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X
    Bucksch, Karolin
    Zachariae, Silke
    Ahadova, Aysel
    Aretz, Stefan
    Buttner, Reinhard
    Goergens, Heike
    Holinski-Feder, Elke
    Hueneburg, Robert
    Kloor, Matthias
    Doeberitz, Magnus Knebel
    Ladigan-Badura, Swetlana
    Moeslein, Gabriela
    Morak, Monika
    Nattermann, Jacob
    Huu Phuc Nguyen
    Perne, Claudia
    Redler, Silke
    Schmetz, Ariane
    Steinke-Lange, Verena
    Surowy, Harald
    Vangala, Deepak B.
    Weitz, Juergen
    Loeffler, Markus
    Engel, Christoph
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (01) : 56 - 66